ZS Zscaler, Inc.

BEARISH Impact: 1/10 ANALYST-DOWNGRADE
Processed 1mo ago SEC analyst-ZS-morganst-20260422
Morgan Stanley double downgrade: Overweight → Equal-Weight
Latest settled — T+20d
ZS ▲ +23.41% at T+20d
SHORT call ✗ call lost -23.41% · α vs SPY -20.25% · entry $142.00 → $175.25
Next anchor: T+60d in 6w
Currently $130.78 · +7.90% from $142.00 entry (call sign-flipped)
Entry anchored
Apr 22, 11:49 AM ET
via Databento tick
T+1d
-6.75%
call +6.75% · α +6.35%
$132.42
settled 6w ago
T+5d
-6.80%
call +6.80% · α +6.86%
$132.34
settled 5w ago
T+20d
+23.41%
call -23.41% · α -20.25%
$175.25
settled 17d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Morgan Stanley downgraded the stock from Overweight to Equal-Weight with a reduced price target of $155, down from $200, citing deteriorating near-term momentum. The firm has a 57% accuracy rate (4/7 calls correct), below its historical average and well below top-tier firms like Stephens & Co. (100%, 3/3). Consensus remains bullish: 86% Buy/Strong Buy (49 of 58 analysts), with a mean PT of $230.45, implying 65% upside from current levels of $139.61. EPS estimates are stable, though revisions have slowed, with only 1 downward revision in the past 30 days across FY1. Insider selling totaled over $1.3M in March, while institutional activity shows divergence—Morgan Stanley added 25.4%, but Two Sigma trimmed -63.9%. Short ratio remains elevated at 59.6%. Earnings due in 35 days.

Impact Score

Base Score
2/7
LLM Adjustment
-1
Final Score
1/10

Consensus & Targets

Buy / Strong Buy
49 (84%)
Hold
9
Sell / Strong Sell
0
Total Analysts
45
Mean PT
$230.45
Median PT
$225.00
High PT
$335.00
Low PT
$140.00
Current Price
$139.61
Implied Upside
+65.1%

Of 58 total analysts, 86% rate it Buy or Strong Buy (16 Strong Buy, 33 Buy), 16% Hold (9), and 0% Sell or Strong Sell. Consensus direction remains firmly bullish, with no Sell ratings. Morgan Stanley's downgrade is contrarian but not outlier, as BTIG also downgraded to Neutral on April 9. The overall bias remains heavily positive, with 49 of 58 analysts at Buy or above.

The consensus price target mean is $230.45, median $225, high $335, low $140, based on 45 analysts. Current price is $139.61, implying 65% upside to the mean. Morgan Stanley’s $155 PT is 33% below the mean and 22% below the median, placing it in the bottom quartile of targets. It remains above only the $140 low target and is 11% above current price, suggesting limited near-term upside.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-04-22 Morgan Stanley downgrade Equal-Weight $155.00
2026-04-15 Keybanc maintain Overweight $160.00
2026-04-09 BTIG downgrade Neutral
2026-03-10 Oppenheimer maintain Outperform $250.00
2026-03-03 Wells Fargo initiate Overweight $200.00
2026-03-02 Citigroup maintain Buy $195.00
2026-03-02 Goldman Sachs maintain Neutral $257.00
2026-02-27 Macquarie maintain Outperform $210.00
2026-02-27 Canaccord Genuity maintain Buy $275.00
2026-02-27 TD Cowen maintain Buy $220.00

In the past 30 days, there have been 2 downgrades (Morgan Stanley, BTIG) and 0 upgrades. EPS estimates show modest downward pressure: 40 upward revisions in the last 30 days for current year EPS, but 1 downward revision. Next quarter EPS has seen 1 downward revision and no upward revisions in the past 30 days. Revenue estimates remain stable. Momentum in analyst sentiment is neutral-to-slightly negative.

Firm Track Record — Morgan Stanley

Morgan Stanley accuracy: 55% on 4993 calls | avg return: 4.3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Stephens & Co. 100% 3/3 19.8% top tier
Truist Securities 100% 2/2 1.9% top tier
Loop Capital 80% 4/5 10.8% top tier
Barclays 73% 8/11 4.2% top tier
Baird 71% 5/7 8.8% top tier
Stifel 71% 5/7 1% top tier
Bernstein 67% 2/3 -18.5% top tier
Mizuho 64% 7/11 -2% top tier
BMO Capital 63% 5/8 12.1% top tier
Wedbush 60% 3/5 5% above average

Morgan Stanley has a 57% accuracy rate on this stock (4 correct out of 7 rated calls), with an average return of +0.8% on rated stocks—below the top-tier average of +8.5%. Among 15 firms covering the name, Morgan ranks 14th in accuracy. Top performers include Stephens & Co. (100%, +19.8% avg return) and Truist (100%, +1.9%), while Bernstein (67%) and Mizuho (64%) also outperform. This firm's call carries below-average predictive weight.

Earnings Estimates

Next earnings: May 27, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q $1.01 $0.99 — $1.07 $835.8M ↑0 ↓0
+1q $1.04 $1.01 — $1.16 $878.8M ↑0 ↓0
0y $4.03 $3.99 — $4.47 $3.3B ↑0 ↓0
+1y $4.59 $3.81 — $5.23 $4.0B ↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Institutional
TWO SIGMA INVESTMENTS, LP — trim (-63.9%)
Institutional
NORGES BANK — new
Institutional
MORGAN STANLEY — add (25.4%)
Short Interest
Short: 625,300 | Exempt: 2,979 | TRF Vol: 1,049,913 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)

Insiders sold $1.32M worth of shares on March 17–18, including multiple executives. Institutionally, Morgan Stanley added 25.4% to its position, while Two Sigma cut -63.9%, Bank of America -52.9%, and UBS -49.8%. Norges Bank initiated a new stake. Short interest is extremely high at 59.6% short ratio, indicating intense bearish positioning. Insider and institutional signals are mixed, but elevated short interest and insider selling align with Morgan Stanley’s cautious view.

Actionable Insight

Despite a double downgrade from Morgan Stanley, the call is low-conviction given the firm’s subpar accuracy and contrarian position against a 86% Buy consensus. Elevated short interest and insider selling add risk, but mean PT implies 65% upside. Wait for earnings on May 27 before taking contrarian short position.

Documents Analyzed

Report based on filing metadata.

15 reports for ZS
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+1▲ +6.75%May 22, 2026
Filters
Rows
Reports for ZS — sortable, filterable
Type Now
Jun 1, 2026
4d ago
ANALYST-UPGRADE
BULLISH ★ 3/10
awaiting T+5
May 31, 2026
5d ago
ANALYST-UPGRADE
BULLISH ★ 2/10
$232.67 $229.12▼ −1.53%▼ −2.86%$130.78 (−43.79%)
May 27, 2026
9d ago
ANALYST-DOWNGRADE
BEARISH ★ 5/10
awaiting T+5
May 26, 2026
10d ago
8-K
MIXED ★ 6/10
$126.17 $134.28▲ +6.43%▲ +5.96%$130.78 (+3.65%)
May 22, 2026
14d ago
ANALYST-DOWNGRADE
BEARISH ★ 3/10
$142.00 $134.27▲ +5.44%▲ +5.50%$130.78 (+7.90%)
May 21, 2026
15d ago
Press Release
BULLISH ★ 6/10
awaiting T+5
May 19, 2026
17d ago
Press Release
NEUTRAL ★ 4/10
awaiting T+5
May 18, 2026
18d ago
ANALYST-UPGRADE
BULLISH ★ 3/10
awaiting T+5
May 9, 2026
27d ago
ANALYST-DOWNGRADE
BEARISH ★ 3/10
$121.25 $134.28▼ −10.75%▼ −7.56%$130.78 (−7.86%)
May 7, 2026
29d ago
Press Release
NEUTRAL ★ 3/10
$152.03 $152.43▲ +0.26%▼ −1.24%$130.78 (−13.98%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (36h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access